3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
82
Active not recruiting
26
Not yet recruiting
14
Completed
9
Terminated
5
Enrolling by invitation
2
Available
2
Withdrawn
1
Suspended
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Neoplasms
3
Prostatic Neoplasms
2
Multiple Myeloma
2
Lung Neoplasms
2
Leukemia
2
Colorectal Neoplasms
2
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Tinnitus
1
Squamous NSCLC
1
Solid Tumors
1
Sinusitis
1
Rib Fractures
1
Pelvic Pain
1
Ovarian Neoplasms
1
Ototoxicity
1
Non-Muscle Invasive Bladder Neoplasms
1
Mycosis Fungoides
1
Metrorrhagia
1
Menorrhagia
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, B-Cell
1
Lymphoma
1
Leukemia, Myelomonocytic, Chronic
1
Leiomyoma
1
Kidney Neoplasms
1
Hearing Loss
1
Head and Neck Neoplasms
1
Extensive Stage Small Cell Lung Carcinoma
1
Deafness
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Ovarian Neoplasms
×
30 days
×
Clear all
NCT04149145
2026-06-05
PARP
University of Alabama at Birmingham
Phase 1
Withdrawn